Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection

Miehlke, Stephan and Krasz, Susanne and Schneider-Brachert, Wulf and Kuhlisch, Eberhard and Berning, Marco and Madisch, Ahmed and Laass, Martin W. and Neumeyer, Michael and Jebens, Claus and Zekorn, Christian and Knoth, Holger and Vieth, Michael and Stolte, Manfred and Lehn, Norbert and Morgner, Andrea (2011) Randomized Trial on 14 versus 7 days of Esomeprazole, Moxifloxacin, and Amoxicillin for Second-line or Rescue Treatment of Helicobacter pylori Infection. HELICOBACTER, 16 (6). pp. 420-426. ISSN 1083-4389, 1523-5378

Full text not available from this repository. (Request a copy)

Abstract

Background: Triple therapy with a proton pump inhibitor, moxifloxacin, and amoxicillin has been proven effective in first-line treatment of Helicobacter pylori infection.

Item Type: Article
Uncontrolled Keywords: TRIPLE THERAPY; ANTIBIOTIC-RESISTANCE; QUADRUPLE THERAPY; TREATMENT FAILURE; 1ST-LINE TRIPLE; LEVOFLOXACIN; ERADICATION; CLARITHROMYCIN; GASTROENTEROLOGY; METRONIDAZOLE; Helicobacter pylori; moxifloxacin; levofloxacin; fluoroquinolone
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Depositing User: Dr. Gernot Deinzer
Date Deposited: 27 May 2020 05:19
Last Modified: 27 May 2020 05:19
URI: https://pred.uni-regensburg.de/id/eprint/19762

Actions (login required)

View Item View Item